Filter News
Area of Research
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (17)
- Clean Energy (9)
- Computational Biology (1)
- Fusion and Fission (2)
- Isotopes (4)
- Materials (29)
- Materials for Computing (6)
- National Security (3)
- Neutron Science (12)
- Nuclear Science and Technology (2)
- Quantum information Science (1)
- Supercomputing (27)
News Type
News Topics
- (-) Biomedical (29)
- (-) Exascale Computing (25)
- (-) Materials Science (54)
- (-) Nanotechnology (20)
- 3-D Printing/Advanced Manufacturing (43)
- Advanced Reactors (9)
- Artificial Intelligence (47)
- Big Data (27)
- Bioenergy (52)
- Biology (60)
- Biotechnology (12)
- Buildings (24)
- Chemical Sciences (26)
- Clean Water (15)
- Climate Change (54)
- Composites (7)
- Computer Science (88)
- Coronavirus (18)
- Critical Materials (3)
- Cybersecurity (14)
- Decarbonization (50)
- Education (1)
- Emergency (2)
- Energy Storage (35)
- Environment (110)
- Fossil Energy (4)
- Frontier (25)
- Fusion (33)
- Grid (25)
- High-Performance Computing (44)
- Hydropower (5)
- Isotopes (28)
- ITER (2)
- Machine Learning (23)
- Materials (44)
- Mathematics (7)
- Mercury (7)
- Microelectronics (2)
- Microscopy (23)
- Molten Salt (1)
- National Security (40)
- Net Zero (8)
- Neutron Science (50)
- Nuclear Energy (60)
- Partnerships (16)
- Physics (33)
- Polymers (11)
- Quantum Computing (20)
- Quantum Science (31)
- Renewable Energy (1)
- Security (12)
- Simulation (31)
- Software (1)
- Space Exploration (12)
- Statistics (1)
- Summit (30)
- Sustainable Energy (47)
- Transformational Challenge Reactor (3)
- Transportation (32)
Media Contacts
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
A collaboration between the ORNL and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.
Soteria Battery Innovation Group has exclusively licensed and optioned a technology developed by Oak Ridge National Laboratory designed to eliminate thermal runaway in lithium ion batteries due to mechanical damage.
About 60 years ago, scientists discovered that a certain rare earth metal-hydrogen mixture, yttrium, could be the ideal moderator to go inside small, gas-cooled nuclear reactors.
Scientists at ORNL and the University of Nebraska have developed an easier way to generate electrons for nanoscale imaging and sensing, providing a useful new tool for material science, bioimaging and fundamental quantum research.
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
Scientists seeking ways to improve a battery’s ability to hold a charge longer, using advanced materials that are safe, stable and efficient, have determined that the materials themselves are only part of the solution.
From materials science and earth system modeling to quantum information science and cybersecurity, experts in many fields run simulations and conduct experiments to collect the abundance of data necessary for scientific progress.